Improving Depression, and Quality of Life in Patients with Type 2 Diabetes: Using Group Cognitive Behavior Therapy
AbstractObjective: Comorbidity with depression is a critical issue in dealing with diabetes type 2. Any intervention for diabetes treatment must consider the psychological dimensions associated with it. The aim of the present study is to assess the effectiveness of group cognitive behavior therapy (CBT) on depression and quality of life of women with diabetes type 2.Method: The sample included 30 diabetic women comorbid with depression who were randomly divided into the experimental and control groups. The subjects received 10 sessions of group cognitive behavioral therapy and filled out Beck s Depression Inventory (BDI) and Quality of Life Scales befor and after the intervention.Results: Using MANCOVA shows that the intervention in the experimental group decreased the depression symptoms (F=72.17, p<0.001) and improved quality of life(F=8.82, p<0.05) in the compared to the control group. The results were statistically significant at p<0/05.Conclusion : The findings suggest that applying cognitive behavior therapy could help in decreasing the psychological symptoms related to diabetes type 2 and subsequently increase the patients’ quality of life.
Strandberg RB, Graue M, Wentzel-Larsen T, Peyrot M, Rokne B. Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-being with HbA 1c in adult persons with type 1 diabetes. J Psychosom Res 2014; 77: 174-179.
Ludman EJ, Katon W, Russo J, Von Korff M, Simon G, Ciechanowski P, et al. Depression and diabetes symptom burden. Gen Hosp Psychiatry 2004. 26: 430-436.
Wildermuth SA. Cognitive Behavioral Group Therapy for Adolescents with Type I Diabetes. ProQuest; 2008.
Renn BN, Feliciano L, Segal DL. The bidirectional relationship of depression and diabetes: a systematic review. Clin Psychol Rev 2011; 31: 1239-1246.
Lloyd CE, Roy T, Nouwen A, Chauhan AM. Epidemiology of depression in diabetes: International and cross-cultural issues. J Affect Disord 2012; 142.
Molosankwe I, Patel A, José Gagliardino J, Knapp M, McDaid D. Economic aspects of the association between diabetes and depression: a systematic review. J Affect Disord 2012; 142: S42-55.
Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord 2012; 142: S8-21.
Egede LE, Ellis C. Diabetes and depression: Global perspectives. Diabetes Res Clin Pract 2010; 87: 302-312.
Fisher EB, Chan JC, Nan H, Sartorius N, Oldenburg B .Co-occurrence of diabetes and depression: Conceptual considerations for an emerging global health challenge. J Affect Disord 2012; 142: S56-66.
Chyun DA, Melkus GD, Katten DM, Price WJ, Davey JA, Grey N, et al. The association of psychological factors, physical activity,
neuropathy, and quality of life in type 2 diabetes. Biol Res Nurs 2006; 7:279-288.
Goldney RD, Phillips PJ, Fisher LJ, Wilson DH.Diabetes, depression and quality of life: a population study. Diabetes care 2004; 27:1066-1070.
Hasan SS, Clavarino AM, Mamun AA, Doi SA, Kairuz T. Population impact of depression either as a risk factor or consequence of type 2 diabetes in adults: A meta-analysis of longitudinal studies. Asian Journal of Psychiatry 2013; 6: 460-472.
Fisher EB Jr, Delamater AM, Bertelson AD, Kirkley BG. Psychological factors in diabetes and its treatment. J Consult Clin Psychol 1982; 50: 993-1003.
Rustad JK, Musselman DL, Nemeroff CB. The relationship of depression and diabetes: Pathophysiological and treatment implications. Psychoneuroendocrinology 2011; 36: 1276-1286.
Safren SA, Gonzalez JS, Wexler DJ, Psaros C, Delahanty LM, Blashill AJ. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care 2014; 37: 625-633.
Gonzalez JS, McCarl LA, Wexler D DD, Cagliero E, Delahanty L, Soper TD. Cognitive behavioral therapy for adherence and depression (CBT-AD) in type 2 diabetes. J Cogn Psychother 2010; 24: 329-343.
Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus. a randomized, controlled trial. Ann Intern Med 1998; 129: 613-621.
Honarmand, MM. The effect of cognitive therapy in reducing depression and increasing coordination components of self-concept, in department of psychology. Tehran: Tarbiat Modarres University; 1996.
Omranifard V, et al. [The effectiveness of psychological interventions adjusted to unburden and improve the quality of life of families of patients with bipolar disorder type 1 (persian)]. Journal of Isfahan Medical School 2009; 27.
nasiri h. [Validity and Reliability of quality of life scale, the World Health Organization and its Iranian version, in The sets of third seminar articles of Mental Health (persian)]. Jornal of school of public health and institute of health research 2006; 4: 1-12.
Van Bastelaar KM, Pouwer F, Cuijpers P, Twisk JW, Snoek FJ. Web-based cognitive behavioural therapy (W-CBT) for diabetes patients with co-morbid depression: design of a randomised controlled trial. BMC psychiatry 2008 .
Esbitt SA, Batchelder AW, Tanenbaum ML, Shreck E, Gonzalez JS.“Knowing That You’re Not the Only One”: Perspectives on Group-Based Cognitive-Behavioral Therapy for Adherence and Depression (CBT-AD) in Adults With Type 1 Diabetes. Cogn Behav Pract 2015; 22: 393-406.
Snoek FJ, Skinner TC. Psychological counselling in problematic diabetes: does it help? Diabet Med 2002; 19: 265-273.
Unwin G, Tsimopoulou I, Kroese BS, Azmi S. Effectiveness of cognitive behavioural therapy (CBT) programmes for anxiety or depression in adults with intellectual disabilities: A review of the literature. Res Dev Disabil 2016; 51–52: 60-75.
Watts SE, Turnell A, Kladnitski N, Newby JM, Andrews G. Treatment-as-usual (TAU) is anything but usual: A meta-analysis of CBT versus TAU for anxiety and depression. Journal of Affective Disorders 2015; 175: 152-167.
Joensen LE, Almdal TP, Willaing I. Associations between patient characteristics, social relations, diabetes management, quality of life, glycaemic control and emotional burden in type 1 diabetes. Prim Care Diabetes 2016; 10: 41-50.
Almeida OP, McCaul K, Hankey GJ, Yeap BB, Golledge J, Norman PE, et al. Duration of diabetes and its association with depression in later life: The Health In Men Study (HIMS). Maturitas 2016; 86: 3-9.
Farrell SP, Hains AA, Davies WH, Smith P, Parton E. The impact of cognitive distortions, stress, and adherence on metabolic control in youths with type 1 diabetes. J Adolesc Health 2004; 34: 461-467.
Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabet Med 2014; 31: 764-772.
Aikens JE. Prospective associations between emotional distress and poor outcomes in type 2 diabetes. Diabetes Care 2012; 35: 2472-2478.
Endevelt R, Peled R, Azrad A, Kowen G, Valinsky L, Heymann AD. Diabetes prevention program in a Mediterranean environment: Individual or group therapy? An effectiveness evaluation. Prim Care Diabetes 2015; 9: 89-95.
Dadgostar H, Firouzinezhad S, Ansari M, Younespour S, Mahmoudpour A, Khamseh ME. Supervised group-exercise therapy versus home-based exercise therapy: Their effects on Quality of Life and cardiovascular risk factors in women with type 2 diabetes. Diabetes Metab Syndr. 201; 10: S30-36.
Semenkovich K, Brown ME, Svrakic DM, Lustman PJ. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs 2015; 75: 577-587.
Siddiqui S. Depression in type 2 diabetes mellitus—A brief review. Diabetes & Metabolic Syndrome. Clinical Research & Reviews 2014; 8: 62-65.
Crews RT, Schneider KL, Yalla SV, Reeves ND, Vileikyte L. Physiological and psychological challenges of increasing physical activity and exercise in patients at risk of diabetic foot ulcers: a critical review. Diabetes Metab Res Rev 2016; 32: 791-804.